1. Home
  2. VNCE vs AKTX Comparison

VNCE vs AKTX Comparison

Compare VNCE & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

N/A

Current Price

$8.52

Market Cap

82.0M

ML Signal

N/A

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

N/A

Current Price

$10.20

Market Cap

15.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VNCE
AKTX
Founded
2002
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.0M
15.4M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
VNCE
AKTX
Price
$8.52
$10.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$5.17
$33.50
AVG Volume (30 Days)
351.2K
79.2K
Earning Date
04-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
132.45
N/A
EPS
0.65
N/A
Revenue
$300,007,000.00
N/A
Revenue This Year
$5.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.98
N/A
Revenue Growth
2.23
N/A
52 Week Low
$1.95
$0.12
52 Week High
$8.20
$29.32

Technical Indicators

Market Signals
Indicator
VNCE
AKTX
Relative Strength Index (RSI) 64.87 53.55
Support Level $5.81 $9.20
Resistance Level N/A $15.50
Average True Range (ATR) 0.72 1.30
MACD 0.12 0.14
Stochastic Oscillator 95.66 54.76

Price Performance

Historical Comparison
VNCE
AKTX

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale and Vince Direct-to-consumer. It operates its e-commerce business through its website. Maximum of its revenue generated from Vince Wholesale segment.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the spliceosome, a complex machinery in the cell that converts pre-RNA into spliced RNA for translation into vital proteins for cell survival and growth. Its product pipeline is AKTX-101, which targets the Trop2 receptor on cancer cells and, with a proprietary linker, enables it to deliver its novel PH1 payload directly into the tumor with minimal off-target effects. and AKTX-102, an ADC candidate targeting CEACAM5 (Carcinoembryonic Antigen-related Cell Adhesion Molecule-5), a well-validated tumor antigen expressed across multiple solid tumors.

Share on Social Networks: